Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Biogen Poaches Merck Exec to Lead New Marketing Team November 2, 2017 New CEO Takes Over Rapamycin, Leads Funding Round With Plans for IND August 6, 2017 Ballsy Celgene Continues to Tread Carefully Into Neurosciences January 25, 2018